Today: 21 May 2026
NuScale Power stock jumps 15% to start 2026 — what pushed SMR, and what’s next
4 January 2026
1 min read

NuScale Power stock jumps 15% to start 2026 — what pushed SMR, and what’s next

NEW YORK, January 4, 2026, 06:46 ET — Market closed

  • NuScale Power shares closed up 15.1% on Friday, outpacing a steadier broader market start to 2026.
  • Commentary around the move pointed to sector sentiment rather than a fresh company announcement.
  • Traders now shift focus to a heavy U.S. data week, including the January 9 jobs report, for clues on rates and risk appetite.

NuScale Power Corporation shares jumped 15.1% in the last regular session, closing at $16.31 on Friday with about 30.5 million shares traded, according to Stock Analysis data.

The move put the small-cap nuclear developer among the sharper gainers as investors began 2026 rotating back into higher-volatility corners of the market after a late-December slump.

For NuScale, market chatter centered on sentiment rather than a new company catalyst. Nasdaq.com said the stock rose “apparently on no good news at all,” pointing instead to headlines around a temporary shutdown at Finland’s Olkiluoto nuclear plant. Nasdaq

The Nasdaq.com report cited a technical fault tied to a software update that took one Olkiluoto unit offline, while noting the incident did not compromise safety and other units continued operating.

NuScale develops small modular reactors, or SMRs—smaller nuclear units intended to be built with repeatable, factory-style components rather than custom-built entirely on site.

In essential background, the U.S. Nuclear Regulatory Commission approved NuScale’s upgraded 77-megawatt SMR design in 2025, a milestone the company has said is key to marketing its technology, even as it still seeks firm customer commitments.

The broader nuclear theme has also been tied to rising electricity demand from data centers and a policy push to accelerate reactor approvals, Reuters has reported.

Investors tracking the group have also been watching other nuclear-linked names across the value chain, including SMR developer Oklo and fuel supplier Centrus Energy, among others.

Technically, NuScale is still well below its longer-term moving averages, with MarketBeat listing a 50-day moving average of $23.44 and a 200-day moving average of $34.24—levels some traders treat as overhead resistance after sharp rebounds.

Joe Mazzola, head of trading & derivatives strategist at Charles Schwab, described the broader tape on Friday as a “buy the dip, sell the rip” mentality, while warning investors were becoming more conscious about what they pay for higher-multiple themes. Reuters

With U.S. markets reopening Monday, investors will take their cues from a packed calendar that includes ISM manufacturing on January 5 and a cluster of labor-market indicators midweek.

The main macro test is Friday’s U.S. employment report for December, due January 9, which often resets expectations for Federal Reserve policy and can swing high-beta stocks.

Stock Market Today

  • Nifty 50 and Sensex Expected to Open Higher on May 21 Amid US-Iran Ceasefire Hopes
    May 20, 2026, 10:38 PM EDT. Indian stock indices Sensex and Nifty 50 are poised for a positive start on May 21, following global market gains and optimism over a US-Iran ceasefire deal. The Sensex gained 117.54 points to close at 75,318.39 and Nifty 50 rose 41 points to 23,659 on May 20. Technical analysts highlight a sideways trading range with key Sensex support at 74,500 and resistance near 76,000. Nifty 50 shows bullish candlestick patterns, suggesting buying strength near lower levels and a breakout above 23,800 could trigger further gains. Derivatives data show call and put writing aligning with these support and resistance zones, indicating cautious but optimistic market sentiment.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus
Previous Story

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Baidu stock today: BIDU jumps on Kunlunxin Hong Kong IPO plan as AI-chip frenzy builds
Next Story

Baidu stock today: BIDU jumps on Kunlunxin Hong Kong IPO plan as AI-chip frenzy builds

Go toTop